| Country | Antimalarial | Convulsions | Streptococcal sore throat | Deworming | ||
|---|---|---|---|---|---|---|
| Oral | IM-Preferral | |||||
| Afghanistan | CHQ | SP | QUI | DIA | MEB* | |
| Djibouti | CHQ | SP | QUI | DIA or MED | PEN V or AMO# | MEB* |
| Egypt | -- | -- | -- | SV | BP | -- |
| Iran (Islamic Republic of) | (physicians only) | (physicians only) | PEN V | -- | ||
| Iraq | CHQ Pyrimethamine^ | SP" | -- | DIA | BP or AMO (ERY)# | -- |
| Morocco | -- | -- | -- | DIA or MED | AMO or PEN V, BP (ERY)# | -- |
| Occupied Palestinian territory | -- | -- | -- | DIA | BP (ERY)# | -- |
| Oman | (Hospital management only) | -- | PEN V | -- | ||
| Pakistan | ACTo | -- | QUI | DIA | BP or AMO | MEB |
| Syrian Arab Republic | -- | -- | -- | SV | BP (ERY)# | -- |
| Sudan | ACTo | ACTo | QUI | DIA | -- | -- |
| Tunisia | -- | -- | -- | DIA | BP or AMO, PEN V (ERY) | -- |
| Yemen | ACTo | ACTo | ART sup or QUI | DIA | PEN V or BP | MEB* |
IM=intramuscular; ACT = Artemisinin-base Combination Therapy; AMO = Amoxicillin; ARTsup = Artesunate suppositories; BP = Benzathine-penicillin; CHQ = Chloroquine; DIA = Diazepam; MEB = Mebendazole; MED = Medazolam; PEN V = Penicillin V (Erythromycin if allergic to penicillin); PP = Pyrantel pamoate; QUI = Quinine; SP = Sulfadoxine-pyrimethamine; SV = Sodium valproate;
#STREPTOCOCCAL SORE THROAT
Djibouti: AMO for children 2 up to 12 months old, PEN V for older children; ERY for those allergic to penicillin.
Iraq: If BP not available, AMO given for 10 days; ERY for those allergic to penicillin
Morocco: AMO for children less than 2 years old, PEN V for those 24 up to 36 months old, BP for older children; ERY for those allergic to penicillin.
Occupied Palestinian territory, Syrian Arab Republic, Tunisia: ERY for children allergic to penicillin.
" SULFADOXINE-PYRIMETHAMINE
Iraq: Not to be given to children less than 2 years old
* MEBENDAZOLE:
Afghanistan: Child 1 year old or older and no dose in the previous 6 months: 250mg if child 2 yr
Djibouti: If Ancylostomiasis and Oxyuriasis are endemic in the Region, child is 2 years old or older, and no dose in the previous 6 months: 500mg
Pakistan: Child 1 year old or older and no dose in the previous 6 months: 500mg
Yemen: Child 2 years old or older and no dose in the previous 6 months: 500mg
^ PYRIMETHAMINE:
Iraq: To be given following chloroquine in all children more than 1 year of age, except for children with G-6-PD or specific contra-indication
Sulfadoxine-pyrimethamine (SP) not to be given to children less than 2 years old
oACT (Artemisinin-base Combination Therapy ):
Pakistan ACT includes first-line treatment with artesunate + sulfadoxine-pyrimethamine (SP)
Sudan, Yemen: ACT specifically includes:
a) First-line treatment: Artesunate + sulfadoxine-pyrimethamine (SP);
b) Second-line treatment: Artemether + lumefantrine
